OVER-PATCH HAVING IMPROVED COMPATIBILITY AND A LONG ADHESION DURATION AND METHOD FOR PRODUCING SAID OVER-PATCH

Abstract

The invention relates to a medical product for a fastening duration of at least 7 days having good skin compatibility. The medical product includes a central adhesive compartment (3) and an over-patch. The over-patch is free of active ingredients and is formed from a water-vapor-permeable back layer (1) and an adhesive polymer layer (2) that is free of active ingredients. The invention further relates to a method for the production of the foregoing medical product, and to kits of parts containing laminates of layers 1 and 2.

Description

The present invention relates to medical products which are worn on the skin and fastened by an overplaster. These products may be transdermal therapeutic systems (ITS) which, besides the part containing active ingredient. additionally an active-ingredient-free overplaster, which has a specific construction, but also diagnostic agents or cannulas which are fixed by a plaster dressing. As is known, TTS are medicinal products in patch form which are adhered to the skin and are required to deliver at least one active ingredient over the entire administration time. It is obvious that these medical, properties must, adhere well, since otherwise there can be no delivery of active ingredient to the skin, the diagnostic agent does not work reliably, or the cannula slips. At the same time, instances of skin irritation must be prevented, meaning that the inherent tack of the TTS diagnostic agent or cannula fixing plaster may not be higher than is absolutely necessary.

Adhesive bonding, as is known, refers to the joining of two surfaces by an adhesive that connects the surfaces to one another through adhesion and cohesion. The adhesive here has to wet the respective surfaces. It follows from this that effective tack is governed not only by the adhesive but also by the nature of the surfaces. But different people, particularly with progressing age, have skins with different surfaces, with the individual skin types varying in their sensitivity of reaction to skin irritations. Although this requirement is familiar to the art, there are still no medical products which address this issue.

EP 1 992 363 discloses a transdermal patch having a backing layer and a pressure-sensitively adhering layer, which in turn comprises an active ingredient reservoir layer and a layer which adheres on the skin. The active ingredient reservoir layer comprises a pressure-sensitive acrylate adhesive, while the layer that adheres to the skin comprises a styrene-isoprene-styrene block copolymer.

DE 10 2004 038 285 A1 discloses a patch system for the release of essential oils via the ambient air or transdermally without irritation to the mucosae or the skin. The patch system comprises a polymer matrix in which at least one essential oil is homogeneously distributed, a support layer, and a removable protective layer. Additionally, there may be a blockage layer impermeable to essential oils, a permeation-controlling membrane or a pressure-sensitive adhesive layer present.

Subject-matter of DE 10 2006 054 731 A1 is a transdermal therapeutic system for administering buprenorphine. This system comprises a backing layer impermeable for the active ingredient, a matrix layer based on polysiloxane or polyisobutylene, and comprising as well as buprenorphine at least one carboxylic acid, and a detachable protective layer.

Disclosed in EP 2 759 294 A1 is a patch for the transdermal administration of fentanyl or a fentanyl homolog. The patch comprises a backing layer, a barrier layer, a pressure-sensitively adhering active ingredient layer, and a removable protective layer (release layer). The active-ingredient-containing layer contains fentanyl or a fentanyl homolog, an agent for improving the permeation of the fentanyl or the fentanyl homolog, and an acrylate adhesive. The acrylate adhesive is either a nonfunctional polyacrylate adhesive or a polyacrylate adhesive which contains carboxyl groups.

Plasters of polyacrylates which can be utilized over a wear time of up to at least 7 days are known from U.S. 2009/0130130 A1, for example. Particularly when worn for a long time, plasters of this kind lead generally, on redetachment, to significant pain for spasmolytics, antihypertensives, psychopharmaceuticals, migraine agents, corticoids, analgesics, anticontraceptives, antirheumatics, anticholinergics, sympatholytics, sympathomimetics, vasodilators, anticoagulants and antiarthythmics.

Possible additions dependent on the polymer employed and on the active ingredient are plasticizers, tackifiers, stabilisers, carriers, diffusion- and penetration-regulating additions, or fillers. The physiologically unobjectionable substances contemplated are known.

The layer 2 may contain 0 to 5% (w/w) of a neutral oil, based, on the dry weight of this layer, as compatibilizer. Layer 2 may also contain 0.5 to 5% (w/w) of dexpanthenol, based on the dry weight of this layer.

Layer may also comprise a non-amine-resistant polysiloxane polymers in which, after the polycondensation of the resin fraction and of the polydimethylsiloxanol groups, the remaining silanol groups still free have not been capped by methyl groups, to which 0 to 4% (w/w) of silicons oil are added, based on the dry weight of this layer.

Layer 2 may further comprise polyacrylates or vinyl-acrylate copolymers which have an acid number of less than 1.

Layer 2, finally, may also comprise styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers in combination with hydrogenated hydrocarbon resins and/or oils such as liquid paraffin.

In particular, the preferred TTS has the stated layers in each case once, and it consists preferably of the stated layers. The two stated pressure-sensitively adhering layers may be alike or different in terms of their polymer composition and/or thickness. The pressure-sensitively adhering polymer layer for application to the skin isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or the homo- and/or copolymers thereof. The kit preferably comprises at least two active-ingredient-free overplasters as defined and laminated onto an intermediate carrier, said overplasters differing in terms of the composition, of the layer 2, their size and/or their shape. With this preferred embodiment, the user obtains a “construction kit” allowing them to combine the compartment 3, manufactured in a standardized process and meeting strict pharmaceutical stipulations, with a suitable overplaster allowing the medical product to be used in accordance with the requirements for a fixing time of at least 7 days and are the same time meeting the requirements for good skin compatibility.

The invention further relates to a kit-of-parts comprising

• • at least two active-ingredient-free overplasters laminated onto an intermediate carrier and composed of
    • a) a water vapor-permeable backing layer (1) and
    • b) a pressure-sensitively adhering, active-ingredient-free polymer layer (2) comprising non-amine-resistant, highly water vapor-permeable polysiloxanes, polyacrylates without or only with few free acid groups, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or the homo- and/or copolymers thereof,where the overplasters differ in terms of the composition of the layer 2, their size and/or their shape.

With this kit as well, the user obtains a “construction kit” allowing them to combine the compartment 3, manufactured in a standardized process and meeting strict pharmaceutical stipulations, with a suitable overplaster, allowing the medical product to be utilised in accordance with the requirements tor a fixing time of at least 7.

Claims

1. A medical product comprising a central compartment and an active-ingredient-free overplaster, said overplaster comprising a) a water vapor-permeable backing layer andb) a pressure-sensitively adhering, active-ingredient-free polymer layer,wherein the central compartment is pressure-sensitively adhering and has direct skin contact after removal of the a redetachable protective layer,the overplaster fixes the central compartment and overhangs the central compartment on all sides andthe active-ingredient-free polymer layer comprises non-amine-resistant, highly water vapor-permeable polysiloxanes, polyacrylates or vinyl acetate-acrylate copolymers without free acid groups or with an acid number of less than 1, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers.

2. The medical product as claimed in claim 1, wherein said medical product is a transdermal therapeutic system (TTS) and the central compartment of comprises a) at least one pressure-sensitively adhering, active-ingredient-containing polymer layer which has direct skin contact after removal of the redetachable protective layer, andb) a separating layer which covers the active-ingredient-containing polymer layer.

3. The medical product as claimed in claim 1, wherein said product is a diagnostic agent and the a diagnosis apparatus is located in the central compartment.

4. The medical product as claimed in claim 1, wherein said product is a cannula fixing plaster and the cannula is located in the central compartment.

5. The medical product as claimed in claim 1, wherein the active-ingredient-free polymer layer comprises 0 to 5% (w/w) of a neutral oil, based on the layer dry weight, as compatibilizer.

6. The medical product as claimed in claim 1, wherein the active-ingredient-free polymer layer comprises 0.5 to 5% (w/w) of dexpanthenol, based on the layer dry weight.

7. The medical product as claimed in claim 1, wherein the active-ingredient-free polymer layer comprises non-amine-resistant polysiloxane polymers in which, after polycondensation of a resin fraction and the polydimethylsiloxanol groups, the remaining silanol groups that are still free have not been capped by methyl groups.

8. The medical product as claimed in claim 1, wherein the active-ingredient-free polymer layer comprises 0 to 4% (w/w) of silicone oil, based on the layer dry weight.

9. The medical product as claimed in claim 1, wherein the backing layer comprises an elastic fabric permeable to water.

10. The medical product as claimed in claim 1, wherein the active-ingredient-free polymer layer comprises styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers in combination with hydrogenated hydrocarbon resins and/or oils.

11. A method for producing a medical product as claimed in claim 1, said method comprising producing the central compartment and lining a skin-side adhesive face of said central compartment with a redetachable protective layer which protrudes on all sides by at least 4 mm,classifying a patient's skin type and then, with the aid of this classification, selecting polymer. from a group encompassing non-amine-resistant, highly water vapor-permeable polysiloxanes, polyacrylates or vinyl acetate-acrylate copolymers without free acid groups or with an acid number of less than 1, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or their homo- and/or copolymers, of those polymers—and, optionally, selecting and adding additions necessary for the medical product to be utilized for a fixing time of at least 7 days while meeting requirements for good skin compatibility,producing coating material from said polymer and optional additions and coating said coating material onto an intermediate carrier and drying the coated material to form an active-ingredient-free polymer layer/intermediate carrier laminate,laminating the backing layer onto the active-ingredient-free polymer layer/intermediate carrier laminate, and punching out an overplaster from the foregoing laminate in a size and shape which overhangs the central compartment on all sides by at least 4 mm, andadhering the overplaster, after removing the intermediate carrier, to a side of the central compartment that is facing away from the skin-side adhesive face, such that said overplaster overhangs the central compartment on all sides by at least 4 mm.

12. A kit-of-parts comprising a central compartment as claimed in claim 1 which is provided on its skin-side adhesive face with a redetachable protective layer, andat least one active-ingredient-free overplaster which is laminated to an intermediate carrier and is comprised of a) a water vapor-permeable backing layer andb) a pressure-sensitively adhering, active-ingredient-free polymer layer comprising non-amine-resistant, highly water vapor-permeable polysiloxanes, polyacrylates or vinyl acetate-acrylate copolymers without free acid groups or with an acid number of less than 1, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or the homo- and/or copolymers thereof, the overplaster being large enough to overhang the central compartment on all sides.

13. The kit-of-parts as claimed in claim 12, comprising at least two active-ingredient-free overplasters as claimed in claim 12 that are laminated onto intermediate carriers, said overplasters differing in composition of their active-ingredient-free polymer layers, their size and/or their shape.

14. A kit-of-parts comprising at least two active-ingredient-free overplasters, each overplaster laminated onto an intermediate carrier and further comprising a) a water vapor-permeable backing layer andb) a pressure-sensitively adhering, active-ingredient-free polymer layer comprising non-amine-resistant, highly water vapor-permeable polysiloxanes, polyacrylates without free acid groups or with an acid number of less than 1, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or the homo- and/or copolymers thereof,wherein, the overplasters differ in the composition of their active-ingredient-free polymer layers, their size and/or their shape.

15. The kit-of-parts as claimed in claim 12, wherein the active-ingredient-free polymer layer comprises 0 to 5% (w/w) of a neutral oil based on the layer dry weight, as compatibilizer.

16. A medical product comprising a kit-of-parts as claimed in claim 12, said kit comprising a central compartment andan active-ingredient-free overplaster comprising a) a water vapor-permeable backing layer andb) a pressure-sensitively adhering, active-ingredient-free polymer layer which is not amine-resistant and which comprises highly water vapor-permeable polysiloxanes, polyacrylates or vinyl acetate-acrylate copolymers without free acid groups or with an acid number of less than 1, polyisobutylenes, polybutylenes, styrene-isoprene-styrene block copolymers or styrene-butadiene-styrene block copolymers or the homo- and/or copolymers thereof,wherein the central compartment is pressure-sensitively adhering and has direct skin contact after removal of the redetachable protective layer,an intermediate carrier is laminated onto the in which an active-ingredient-free overplaster, andfollowing removal of the intermediate carrier, the active-ingredient-free overplaster is adhered to the central compartment and overhangs the central compartment on all sides.

17. The transdermal therapeutic system as claim in claim 2, wherein said active-ingredient-free overplaster prevents the crystallization of the active ingredient/ingredients in the active-ingredient-containing polymer layer.

18. The transdermal therapeutic system as claimed in claim 2, wherein said active-ingredient-free overplaster reduces the TTS cold flow.

19. The medical product as claimed in claim 2, wherein said separating layer is polyester.

20. The medical product as claimed in claim 9, wherein the fabric is a polyester fabric.

21. The medical product as claimed in claim 10, wherein the oil is liquid paraffin.

22. A method for producing a medical product as claimed in claim 11 wherein the patient's skin type is classified by a W. E. Roberts method.